APA (7th ed.) Citation

Shen, H., Liao, B., Wan, Z., Zhao, Y., You, Z., Liu, J., . . . He, S. (2021). PTOV1 promotes cisplatin-induced chemotherapy resistance by activating the nuclear factor kappa B pathway in ovarian cancer. Molecular therapy. Oncolytics, 20, 499-507. https://doi.org/10.1016/j.omto.2021.02.008

Chicago Style (17th ed.) Citation

Shen, Hongwei, Bing Liao, Zhiyong Wan, Yunhe Zhao, Zeshan You, Jun Liu, Jin Lan, and Shanyang He. "PTOV1 Promotes Cisplatin-induced Chemotherapy Resistance by Activating the Nuclear Factor Kappa B Pathway in Ovarian Cancer." Molecular Therapy. Oncolytics 20 (2021): 499-507. https://doi.org/10.1016/j.omto.2021.02.008.

MLA (9th ed.) Citation

Shen, Hongwei, et al. "PTOV1 Promotes Cisplatin-induced Chemotherapy Resistance by Activating the Nuclear Factor Kappa B Pathway in Ovarian Cancer." Molecular Therapy. Oncolytics, vol. 20, 2021, pp. 499-507, https://doi.org/10.1016/j.omto.2021.02.008.